Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Line Brøndum"'
Autor:
Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen, Lise Saksø Mortensen, Kasper Toustrup, Jens Overgaard, Jan Alsner
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 46-52 (2017)
Background: Blood-based protein biomarkers can be a useful tool as pre-treatment prognostic markers, as they can reflect both variations in the tumor microenvironment and the host immune response. We investigated the influence of a panel of plasma pr
Externí odkaz:
https://doaj.org/article/59adf4d0dd2647b8ba76364d385c6a57
Autor:
Claus Kristensen, Line Brøndum, Jan F. Evensen, Jens Overgaard, C. Maare, Jan Alsner, Jørgen Johansen, Brita Singers Sørensen, Jesper Grau Eriksen, Lisbeth Juhler Andersen, Hanne Primdahl
Publikováno v:
Brøndum, L, Alsner, J, Sørensen, B S, Maare, C, Johansen, J, Primdahl, H, Evensen, J F, Kristensen, C A, Andersen, L J, Overgaard, J & Eriksen, J G 2018, ' Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial ', Acta Oncologica, vol. 57, no. 9, pp. 1159-1164 . https://doi.org/10.1080/0284186X.2018.1464664
Brøndum, L, Alsner, J, Sørensen, B S, Maare, C, Johansen, J, Primdahl, H, Evensen, J F, Kristensen, C A, Andersen, L J, Overgaard, J & Eriksen, J G 2018, ' Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab : results from the DAHANCA 19 trial ', Acta Oncologica, vol. 57, no. 9, pp. 1159-1164 . https://doi.org/10.1080/0284186X.2018.1464664
Brøndum, L, Alsner, J, Sørensen, B S, Maare, C, Johansen, J, Primdahl, H, Evensen, J F, Kristensen, C A, Andersen, L J, Overgaard, J & Eriksen, J G 2018, ' Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab : results from the DAHANCA 19 trial ', Acta Oncologica, vol. 57, no. 9, pp. 1159-1164 . https://doi.org/10.1080/0284186X.2018.1464664
Purpose: To study the associations between development of moderate to severe skin rash, clinical outcome, and single nucleotide polymorphisms (SNPs) in candidate genes in head and neck cancer patients from the DAHANCA 19 trial receiving the EGFR-inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1e936eb750b6dde160b2d983dbcb95
Publikováno v:
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
BACKGROUND: Interleukin-2 (IL2)-based immunotherapy is curative for a small subset of patients with metastatic renal-cell carcinoma (mRCC). Preclinical data suggests that bevacizumab (BEV), a humanized anti-VEGF monoclonal antibody, has potential imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140f3802d1a95917488d380c8e4d37fe
https://pubmed.ncbi.nlm.nih.gov/29392960
https://pubmed.ncbi.nlm.nih.gov/29392960
Autor:
Lise Saksø Mortensen, Brita Singers Sørensen, Jan Alsner, Jens Overgaard, Line Brøndum, Jesper Grau Eriksen, Kasper Toustrup
Publikováno v:
Brøndum, L, Eriksen, J G, Singers Sørensen, B, Mortensen, L S, Toustrup, K, Overgaard, J & Alsner, J 2017, ' Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients ', Clinical and Translational Radiation Oncology, vol. 2, pp. 46-52 . https://doi.org/10.1016/j.ctro.2017.01.001
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 46-52 (2017)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 46-52 (2017)
Clinical and Translational Radiation Oncology
Background: Blood-based protein biomarkers can be a useful tool as pre-treatment prognostic markers, as they can reflect both variations in the tumor microenvironment and the host immune response. We investigated the influence of a panel of plasma pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e442545d3c4653c9d4973d23e115625
https://findresearcher.sdu.dk:8443/ws/files/140885342/Plasma_proteins_as_prognostic_biomarkers_in_radiotherapy_treated_head_and_neck_cancer_patients.pdf
https://findresearcher.sdu.dk:8443/ws/files/140885342/Plasma_proteins_as_prognostic_biomarkers_in_radiotherapy_treated_head_and_neck_cancer_patients.pdf
Autor:
Lise Saksø Mortensen, Brita Singers Sørensen, Simon Lønbro, Line Brøndum, Jens Overgaard, Jan Alsner, Jesper Grau Eriksen
Publikováno v:
Brøndum, L, Sørensen, B S, Eriksen, J G, Mortensen, L S, Lønbro, S, Overgaard, J & Alsner, J 2016, ' An evaluation of multiplex bead-based analysis of cytokines and soluble proteins in archived lithium heparin plasma, EDTA plasma and serum samples ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 76, no. 8, pp. 601-611 . https://doi.org/10.1080/00365513.2016.1230882
Objective: To assess the usability of archived plasma and serum by multiplex (Luminex) analysis of circulating proteins (analytes) by evaluating the day to day variation, the effect of several freeze-thaw cycles, and the influence of the media and ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26138032628ec6e4cd6842dd9d13314
https://pure.au.dk/portal/da/publications/an-evaluation-of-multiplex-beadbased-analysis-of-cytokines-and-soluble-proteins-in-archived-lithium-heparin-plasma-edta-plasma-and-serum-samples(96d39dad-9f24-4c90-9870-5438d935ebd7).html
https://pure.au.dk/portal/da/publications/an-evaluation-of-multiplex-beadbased-analysis-of-cytokines-and-soluble-proteins-in-archived-lithium-heparin-plasma-edta-plasma-and-serum-samples(96d39dad-9f24-4c90-9870-5438d935ebd7).html
Autor:
L. Juhler Andersen, J. Folkvard Evensen, Jan Alsner, J. Overgaard, B. Singers Sørensen, J. Grau Eriksen, C. Andrup Kristensen, Line Brøndum, J. Johansen, Christian Maare, Hanne Primdahl
Publikováno v:
Radiotherapy and Oncology. 127:S223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f4ac33e0d075874c7ba1b2b7a6ab413
https://doi.org/10.1016/s0167-8140(18)30735-7
https://doi.org/10.1016/s0167-8140(18)30735-7
Publikováno v:
Journal of Clinical Oncology. 34:4563-4563
4563Background: The potential benefit of combining the antiangiogenic agent bevacizumab (BEV) with Interleukin-2/Interferon-alpha (IL2/IFN) immunotherapy is unknown. This randomized, open-label, ph...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9a954ee6a9dcb2b153aca1f836a458
https://doi.org/10.1200/jco.2016.34.15_suppl.4563
https://doi.org/10.1200/jco.2016.34.15_suppl.4563